The Discounted Cash Flow (DCF) valuation of Eagle Pharmaceuticals Inc (EGRX) is 151.15 USD. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on DCF is 6962.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 6.7% | 5.9% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 121.24 - 200.93 | 151.15 |
| Upside | 5565.6% - 9289.1% | 6962.9% |